LOR-253 HCl

LOR-253 hydrochloride · Aptose Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LOR-253 HCl, covering 2014-02-25 to 2014-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours [Phase 1]